Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/53385| Type: | Artigo de Periódico |
| Title: | HLA-G 14 bp In/Del and +3142 C/G genotypes are differentially expressed between patients with grade IV gliomas and controls |
| Authors: | Kênia Cristina S.f.de Magalhães Eduardo a. Donadi Istéfani Luciene da Silva Renata t. Simões Karla r. Silva Nathália a. Gomes Ibrahim Sadissou Gérvasio t. Carvalho Marcelo a. Buzellin Luciene s. Tafuri Cristiana Buzelin Nunes Maurício b. Nunes |
| Abstract: | Aim: Human Leukocyte Antigen-G (HLA-G) is a non-classical class I molecule that is involved in maternal–fetal immunotolerance. In cancer, this molecule contributes to the tumor escape. The aim of this study was to evaluate the 14 bp In/Del and þ3142 C > G polymorphisms of the HLAG 30 UTR and its relation with plasma and tissue HLA-G expression in patients with grade IV (high-grade) and grade I/II (low-grade) gliomas and controls. Patients and methods: Peripheral blood and tumor biopsies were collected from 85 patients with gliomas and blood samples from 94 controls. Polymorphisms were analyzed from blood DNA. Soluble HLA-G (sHLA-G) was measured by ELISA in plasma of the subjects and the tissue expression by immunohistochemistry on patient’s tissue. Results: Higher levels of sHLA-G were observed in grade IV gliomas patients than in controls (p < 0.0001). In grade IV patients, the heterozygous 14pb In/Del, þ3142 C/G genotypes and Del/C In/G haplotype were associated with higher sHLA-G levels (p < 0.0001) when compared with controls. GBM patients were stratified into high and low sHLA-G expression and an association was found between þ3142 C allele and high sHLA-G plasmatic levels (p ¼ 0.0095). Tissue HLA-G immunolabel was higher in high-grade than low-grade gliomas (p ¼ 0.0033). Conclusion: This was the first study evaluating HLA-G 30 UTR polymorphisms and expression in patients with gliomas. The 14 bp In/Del and þ3142 C/G genotypes and haplotypes showed high influence over sHLA-G expression, suggesting a heterozygous advantage in the tumor context and may contribute to a worse prognosis in glioma patients. |
| Subject: | Neoplasias Encefálicas Glioma |
| language: | eng |
| metadata.dc.publisher.country: | Brasil |
| Publisher: | Universidade Federal de Minas Gerais |
| Publisher Initials: | UFMG |
| metadata.dc.publisher.department: | MED - DEPARTAMENTO DE ANATOMIA PATOLÓGICA E MEDICINA LEGAL |
| Rights: | Acesso Restrito |
| metadata.dc.identifier.doi: | 10.1080/00207454.2020.1744593 |
| URI: | http://hdl.handle.net/1843/53385 |
| Issue Date: | 2021 |
| metadata.dc.url.externa: | https://www.tandfonline.com/doi/full/10.1080/00207454.2020.1744593 |
| metadata.dc.relation.ispartof: | International Journal of Neuroscience |
| Appears in Collections: | Artigo de Periódico |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.